Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.

Yi, John S; Decroos, Emily C; Sanders, Donald B; Weinhold, Kent J; Guptill, Jeffrey T

doi:10.1002/mus.24063

Type

Subject

Antibodies, Monoclonal, Murine-Derived
Antigens, CD19
B-Lymphocytes
Cell Count
Fatty Acids, Monounsaturated
Female
Humans
Immunologic Deficiency Syndromes
Immunologic Factors
Middle Aged
Myasthenia Gravis
Rituximab

Permalink

https://hdl.handle.net/10161/10207

Published Version (Please cite this version)

10.1002/mus.24063

Publication Info

Yi, John S; Decroos, Emily C; Sanders, Donald B; Weinhold, Kent J; & Guptill, Jeffrey T (2013). Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. Muscle Nerve, 48(6). pp. 992-993. 10.1002/mus.24063. Retrieved from https://hdl.handle.net/10161/10207.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Collections

Scholarly Articles

More Info

Show full item record

Scholars@Duke

Jeffrey Guptill

Associate Professor of Neurology

Donald Benjamin Sanders

Professor of Neurology

Research Interests: 1. Therapy of neuromuscular disease - immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS). 2. Clinical trials in nerve, muscle and neuromuscular diseases

Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

Rights for Collection: Scholarly Articles